CPT® Code 85384 is used to report laboratory testing of fibrinogen activity in the blood. Fibrinogen is a key protein in the coagulation cascade that helps form blood clots. Measuring fibrinogen activity is important for evaluating bleeding disorders, monitoring anticoagulant therapy, assessing risk of thrombosis, and investigating abnormal clotting function. This test provides quantitative information on the functional ability of fibrinogen to contribute to clot formation.
Key Facts About CPT® 85384
Service type: Laboratory coagulation test
Provider type: Physicians and qualified healthcare professionals who order laboratory testing
Medical services included: Yes, quantitative measurement of fibrinogen activity
Specimen type: Plasma (usually citrate anticoagulated)
Test method: Clauss assay or other validated functional assays
Common clinical indications:
- Suspected bleeding disorders (e.g., congenital fibrinogen deficiency, dysfibrinogenemia)
- Monitoring anticoagulant therapy or fibrinogen replacement
- Evaluation of abnormal PT/INR or aPTT results
- Assessment prior to surgery in patients at risk for bleeding
- Thrombotic disorder evaluation or hypercoagulable state assessment
When to Use CPT® 85384
CPT 85384 is appropriate when:
- Quantitative fibrinogen activity measurement is medically necessary
- The test is performed to assess bleeding or clotting function
- Results guide diagnosis, therapy, or monitoring of coagulation disorders
- Proper plasma specimen is collected and processed according to laboratory standards
Examples:
- Evaluating fibrinogen activity in a patient with unexplained bleeding
- Monitoring fibrinogen replacement therapy in a patient with congenital deficiency
- Preoperative assessment of coagulation in a high-risk surgical patient
- Assessing clotting risk in a patient with suspected disseminated intravascular coagulation (DIC)
Documentation Requirements
To support CPT 85384 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication or reason for fibrinogen testing
- Specimen type and collection date
- Test method and quantitative results
- Interpretation and clinical relevance
- Ordering provider credentials and signature
- Laboratory performing the test
Complete documentation ensures compliance, supports reimbursement, and facilitates clinical decision-making.
Reimbursement and Coding Considerations
- CPT 85384 is reimbursed when medically necessary and properly documented
- Coverage depends on payer policies and the clinical indication
- Often ordered alongside other coagulation studies such as PT, aPTT, or platelet function tests
- Proper diagnosis coding should support bleeding disorders, coagulation monitoring, or thrombotic evaluation
- Verify payer-specific laboratory testing guidelines
Accurate coding and thorough documentation help ensure appropriate reimbursement and reduce claim denials.
How OptiMantra Supports Fibrinogen Activity Testing
OptiMantra’s integrated EMR and practice management system streamlines ordering, documentation, and billing for CPT 85384:
With OptiMantra, providers can:
- Order fibrinogen activity testing directly from the patient chart
- Document clinical indication, symptoms, and relevant coagulation history
- Review and track lab values over time within the patient’s longitudinal chart
- Link lab findings to diagnoses, treatment plans, and monitoring workflows
- Support compliant, audit-ready billing codes for coagulation studies
By centralizing laboratory workflows, OptiMantra helps practices improve efficiency, maintain compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
